Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 10 | 2024 | 1237 | 1.920 |
Why?
|
| Tissue Engineering | 5 | 2016 | 67 | 1.220 |
Why?
|
| Oxygen | 2 | 2016 | 321 | 0.820 |
Why?
|
| Anniversaries and Special Events | 1 | 2022 | 3 | 0.810 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 19 | 0.610 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 48 | 0.560 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 153 | 0.560 |
Why?
|
| Patient Participation | 1 | 2017 | 68 | 0.550 |
Why?
|
| Cell Culture Techniques | 3 | 2015 | 97 | 0.520 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 36 | 0.500 |
Why?
|
| Poverty Areas | 3 | 2024 | 37 | 0.500 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 68 | 0.470 |
Why?
|
| Microtechnology | 2 | 2013 | 4 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2017 | 242 | 0.460 |
Why?
|
| Natural Science Disciplines | 1 | 2013 | 1 | 0.440 |
Why?
|
| Insurance Coverage | 2 | 2024 | 110 | 0.270 |
Why?
|
| Poverty | 2 | 2024 | 206 | 0.250 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 19 | 0.230 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 223 | 0.230 |
Why?
|
| Humans | 16 | 2024 | 50389 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 252 | 0.200 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2022 | 31 | 0.200 |
Why?
|
| Ecosystem | 1 | 2022 | 64 | 0.190 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2021 | 10 | 0.190 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 256 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 279 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 32 | 0.180 |
Why?
|
| Models, Biological | 2 | 2013 | 723 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 321 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 209 | 0.150 |
Why?
|
| Rural Population | 1 | 2023 | 552 | 0.150 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2015 | 90 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 600 | 0.140 |
Why?
|
| Kinetics | 1 | 2018 | 635 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 68 | 0.130 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 5 | 0.120 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 8 | 0.120 |
Why?
|
| Alginates | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hydrogels | 1 | 2015 | 17 | 0.120 |
Why?
|
| United States | 2 | 2024 | 4913 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2015 | 86 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 82 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 462 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 269 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 409 | 0.110 |
Why?
|
| Microvessels | 1 | 2013 | 30 | 0.110 |
Why?
|
| Chemical Phenomena | 1 | 2013 | 17 | 0.110 |
Why?
|
| Microfluidics | 1 | 2013 | 6 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 143 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2024 | 667 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 830 | 0.090 |
Why?
|
| Qualitative Research | 2 | 2023 | 338 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 608 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1029 | 0.090 |
Why?
|
| Arkansas | 2 | 2024 | 1991 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2015 | 1625 | 0.070 |
Why?
|
| Aged | 3 | 2024 | 9590 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1178 | 0.060 |
Why?
|
| Middle Aged | 3 | 2024 | 12460 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2024 | 14 | 0.060 |
Why?
|
| Insurance Claim Review | 1 | 2024 | 36 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 13568 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2024 | 124 | 0.050 |
Why?
|
| Focus Groups | 1 | 2023 | 190 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 227 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 590 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 165 | 0.050 |
Why?
|
| Animals | 2 | 2013 | 13173 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 246 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 539 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2021 | 20 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2023 | 196 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 308 | 0.040 |
Why?
|
| Female | 3 | 2024 | 26981 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1590 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Infant | 1 | 2024 | 3601 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2024 | 3908 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4064 | 0.030 |
Why?
|
| Male | 2 | 2024 | 25718 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2013 | 23 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 75 | 0.030 |
Why?
|
| Biological Transport | 1 | 2013 | 171 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 143 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 83 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 147 | 0.030 |
Why?
|
| Adolescent | 1 | 2024 | 6475 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 183 | 0.030 |
Why?
|
| Child | 1 | 2024 | 6877 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2013 | 257 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1589 | 0.020 |
Why?
|